89bio Overview

  • Founded
  • 2018
Founded
  • Status
  • Public
  • Employees
  • 20
Employees
  • Stock Symbol
  • ETNB
Stock Symbol
  • Share Price
  • $29.09
  • (As of Thursday Closing)

89bio General Information

Description

89bio Inc a United States-based clinical-stage biopharmaceutical company focused on the development of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, BIO89-100, is a long-acting glycopegylated fibroblast growth factor 21 (FGF21) analogue.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 535 Mission Street
  • 14th Floor
  • San Francisco, CA 94105
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

89bio Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$29.09 $28.77 $14.00 - $47.25 $490M 16.9M 96.3K -$10.69

89bio Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 189,380 396,070
Revenue 0 0 0
EBITDA (60,096) (57,185) (16,142)
Net Income (60,323) (57,420) (16,176)
Total Assets 76,562 95,553 11,369
Public Fundamental Data provided by Morningstar, Inc. disclaimer

89bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore 89bio‘s full profile, request access.

Request a free trial

89bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
89bio Inc a United States-based clinical-stage biopharmaceutical company focused on the development of therapies for the
Drug Discovery
San Francisco, CA
20 As of 2019
00000
00000000 00000

00000 00

r incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ul
0000 000000000
South San Francisco, CA
00 As of 0000
00000
00000000 00000

000 0000

labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris n
0000000000000
High Point, NC
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

89bio Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Akero Therapeutics Formerly VC-backed South San Francisco, CA 00 00000 00000000 00000
000 000000000000 Formerly PE-Backed High Point, NC 00 00000 00000000 00000
000 00000000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000000 00000
0000 000000 Formerly VC-backed San Diego, CA 00 00000 000000 - 000 00000
0000 00000000000 Formerly VC-backed Redwood City, CA 00 00000 000000&0 00000
You’re viewing 5 of 27 competitors. Get the full list »

89bio Executive Team (5)

Name Title Board Seat Contact Info
Rohan Palekar Chief Executive Officer & Board Member
Ryan Martins Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Ram Waisbourd Chief Operating Officer, Operations & Executive
Quoc Le-Nguyen Chief Technical Operations Officer and Head of Quality
Hank Mansbach MD Chief Medical Officer
To view 89bio’s complete executive team members history, request access »

89bio Board Members (12)

Name Representing Role Since
Anat Naschitz OrbiMed Board Member 000 0000
Cristina Ghenoiu Ph.D Longitude Capital Board Observer 000 0000
Derek DiRocco 89bio Board Member 000 0000
Gregory Grunberg MD Longitude Capital Board Member 000 0000
Lota Zoth Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

89bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

89bio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore 89bio‘s full profile, request access.

Request a free trial